Page last updated: 2024-10-25

clinofibrate and Uremia

clinofibrate has been researched along with Uremia in 2 studies

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research Excerpts

ExcerptRelevanceReference
"We examined the effects of a fibric acid, clinofibrate, on lipoprotein metabolism in 12 hyperlipidemic patients with uremia treated on continuous ambulatory peritoneal dialysis during a 24 week treatment."9.07Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: effect of a fibric acid, clinofibrate. ( Kawasaki, K; Konishi, T; Morii, H; Nishitani, H; Nishizawa, Y; Shoji, T; Yamakawa, M, 1993)
"We examined the effects of a fibric acid, clinofibrate, on lipoprotein metabolism in 12 hyperlipidemic patients with uremia treated on continuous ambulatory peritoneal dialysis during a 24 week treatment."5.07Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: effect of a fibric acid, clinofibrate. ( Kawasaki, K; Konishi, T; Morii, H; Nishitani, H; Nishizawa, Y; Shoji, T; Yamakawa, M, 1993)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishizawa, Y2
Shoji, T2
Nishitani, H1
Yamakawa, M1
Konishi, T1
Kawasaki, K1
Morii, H2
Tabata, T1
Inoue, T1

Trials

1 trial available for clinofibrate and Uremia

ArticleYear
Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: effect of a fibric acid, clinofibrate.
    Kidney international, 1993, Volume: 44, Issue:6

    Topics: Adult; Aged; Animals; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins C; Cholesterol; Fem

1993

Other Studies

1 other study available for clinofibrate and Uremia

ArticleYear
Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients.
    Kidney international. Supplement, 1999, Volume: 71

    Topics: Cholesterol, LDL; Cholesterol, VLDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolip

1999